Factitious Heparin Administration
Authors: ALVlN H. SCHMAIER
Journal: Annals of Internal Medicine (1981)

Brief Reports1 November 1981Factitious Heparin AdministrationALVlN H. SCHMAIER, M.D., JO-ANN CARABELLO, B.S., H. JAMES DAY, M.D., WILLIAM E. BARRY, M.D.ALVlN H. SCHMAIER, M.D.Search for more papers by this author, JO-ANN CARABELLO, B.S.Search for more papers by this author, H. JAMES DAY, M.D.Search for more papers by this author, WILLIAM E. BARRY, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-95-5-592 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptNonmedicinal use of oral anticoagulants was first reported in the medical literature within 6 years after the introduction of these agents into clinical medicine (1). In general, two types of persons abuse these agents: young adults in medical professions and elderly patients previously treated with anticoagulants (1, 2). Most persons who have engaged in factitious anticoagulant use have done so with oral agents. One report described the surreptitious use of heparin, the diagnosis having been made on patient confession (3). We report the covert injection of heparin in another patient and the method used for objective diagnosis.A 21-year-old female...References1. O'REILLY R and AGGELER P. Covert anticoagulant ingestion: study of 25 patients and review of world literature. Medicine (Baltimore). 1976;55:389-99. CrossrefMedlineGoogle Scholar2. BOWIE E, TODD M, THOMPSON J, OWEN C, and WRIGHT I. Anticoagulant malingerers (the "Dicumarol-eaters"). Am J Med. 1965;39:855-64. CrossrefMedlineGoogle Scholar3. MARTIN C, ENGSTROM P, and BARRETT O. Surreptitious self-administration of heparin. JAMA. 1970;212:475-6. CrossrefMedlineGoogle Scholar4. KHOORY M, NESHEIM M, BOWIE E, and MANN K. Circulating heparin sulfate proteoglycan anticoagulant from a patient with a plasma cell disorder. J Clin Invest. 1980;65:666-74. CrossrefMedlineGoogle Scholar5. COWAN J, KHAN M, VARGO J, and JOIST J. An improved method for evaluation of blood coagulation in heparinized blood. Am J Clin Pathol. 1981;75:60-4. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: ALVlN H. SCHMAIER, M.D.; JO-ANN CARABELLO, B.S.; H. JAMES DAY, M.D.; WILLIAM E. BARRY, M.D.Affiliations: Temple University School of Medicine Philadelphia, Pennsylvania PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byIntroductionImproved synthesis and characterization of 1,3,4,6-tetra-O-acetyl-2-(N-acetylacetamido)-2-deoxy-β-d-glucopyranoseThe rate of fibrinopeptide B release modulates the rate of clot formation: a study with an acquired inhibitor to fibrinopeptide B releaseDisseminated Intravascular Coagulation: Pathogenesis and ManagementFurther evaluation of a heparin neutralizer and its effect on factor IX in normal and coumadin-plasmaUnwitting Heparin Abuse in a Drug AddictZEBA MAQBOOL, M.D., H. HEISLER BILLETT, M.D.Heparin and Factitious PurpuraH. CHUL KIM, M.D., MARTIN KOSMIN, M.D. 1 November 1981Volume 95, Issue 5Page: 592-593KeywordsAnticoagulantsElderlyHeparinOral medicineResearch grantsYoung adults ePublished: 1 December 2008 Issue Published: 1 November 1981 PDF downloadLoading ...